Functional Study of HTRA1 and Age-Related Macular Degeneration
About the Research Project
Program
Award Type
Standard
Award Amount
$100,000
Active Dates
April 01, 2008 - March 31, 2010
Grant ID
M2008092
Goals
Identification and functional studies of the HTRA1, a gene that has substantial impact on the risk of AMD, may define key molecular pathways involved in its pathogenesis. The experiments will yield novel mechanistic insights relevant to the pathogenesis of both early and late AMD. This may lead to therapies directed at the underlying cause and pre-symptomatic diagnosis leading to earlier intervention.
Summary
Identification and functional studies of the HTRA1, a gene that has substantial impact on the risk of AMD, may define key molecular pathways involved in its pathogenesis. The experiments will yield novel mechanistic insights relevant to the pathogenesis of both early and late AMD. This may lead to therapies directed at the underlying cause and pre-symptomatic diagnosis leading to earlier intervention.
Related Grants
Macular Degeneration Research
How Retinal Cells Drive Inflammation in Age Related Macular Degeneration
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Sarah Palko, PhD
Current Organization
Trinity College Dublin
How Retinal Cells Drive Inflammation in Age Related Macular Degeneration
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Sarah Palko, PhD
Current Organization
Trinity College Dublin
Macular Degeneration Research
Uncovering the Hidden Link Between Liver Health and Macular Degeneration
Active Dates
July 01, 2026 - June 30, 2029
Principal Investigator
Sunghee Park, PhD
Current Organization
Purdue University
Uncovering the Hidden Link Between Liver Health and Macular Degeneration
Active Dates
July 01, 2026 - June 30, 2029
Principal Investigator
Sunghee Park, PhD
Current Organization
Purdue University
Macular Degeneration Research
Advancing AMD Diagnosis with Novel Spectroscopic Tools
Active Dates
July 01, 2026 - June 30, 2029
Principal Investigator
David Veysset, PhD
Current Organization
Massachusetts General Hospital
Advancing AMD Diagnosis with Novel Spectroscopic Tools
Active Dates
July 01, 2026 - June 30, 2029
Principal Investigator
David Veysset, PhD
Current Organization
Massachusetts General Hospital